- Hops is an essential ingredient for brewing beer and has similar properties to cannabis.
- XXII announced Monday a new subsidiary in the Netherlands where they will develop partnerships for selling strain specific hops.
- They will use their partnerships with CannaMetrix and KeyGene to innovate hops genetics.
- The company reported record revenues for Q2 and expects growth over Q3/Q4 from their hemp/cannabis franchise segment.
- I rate their stock as bullish and recommend a long-hold position.
For further details see:
22nd Century: Third Plant-Based Franchise And Record Q2 Revenues